Author(s): Feng X, Zhou CK, Clish CB, Wilson KM, Pernar CH, Dickerman BA, Loda M, Finn SP, Penney KL, Schmidt DR, Heiden MGV, Giovannucci EL, Ebot EM, Mucci LA|Journal: Cancer Epidemiol Biomarkers Prev|PMID:33627383| August 2021
The gene fusion and loss are two of the most common somatic molecular alterations in prostate cancer. Here, we investigated…
